114 related articles for article (PubMed ID: 16973278)
21. Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide.
Diana A; Simić G; Sinforiani E; Orrù N; Pichiri G; Bono G
Coll Antropol; 2008 Jan; 32 Suppl 1():51-8. PubMed ID: 18405058
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
23. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
24. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
25. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
26. Changes in caspase expression in Alzheimer's disease: comparison with development and aging.
Shimohama S; Tanino H; Fujimoto S
Biochem Biophys Res Commun; 1999 Mar; 256(2):381-4. PubMed ID: 10079193
[TBL] [Abstract][Full Text] [Related]
27. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
Kazmierczak A; Strosznajder JB; Adamczyk A
Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
[TBL] [Abstract][Full Text] [Related]
30. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
[TBL] [Abstract][Full Text] [Related]
31. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease.
Lloret A; Badía MC; Mora NJ; Ortega A; Pallardó FV; Alonso MD; Atamna H; Viña J
Free Radic Biol Med; 2008 Jun; 44(12):2019-25. PubMed ID: 18387371
[TBL] [Abstract][Full Text] [Related]
32. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
33. Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.
Farber SA; Slack BE; Blusztajn JK
FASEB J; 2000 Nov; 14(14):2198-206. PubMed ID: 11053240
[TBL] [Abstract][Full Text] [Related]
34. Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain.
Huang Y; Tanimukai H; Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
Eur J Neurosci; 2004 Dec; 20(12):3489-97. PubMed ID: 15610181
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid signalling through phospholipase D and phosphatidic acid.
Cazzolli R; Shemon AN; Fang MQ; Hughes WE
IUBMB Life; 2006 Aug; 58(8):457-61. PubMed ID: 16916782
[TBL] [Abstract][Full Text] [Related]
36. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism.
Hamblet NS; Ragland B; Ali M; Conyers B; Castora FJ
Electrophoresis; 2006 Feb; 27(2):398-408. PubMed ID: 16358358
[TBL] [Abstract][Full Text] [Related]
37. Activation of intestinal mitochondrial phospholipase D by polyamines and monoamines.
Madesh M; Balasubramanian KA
Biochim Biophys Acta; 1997 Oct; 1348(3):324-30. PubMed ID: 9366248
[TBL] [Abstract][Full Text] [Related]
38. Phase effect of mixed-phospholipid layer on phospholipase D reaction-induced-vesicle rupture.
Park JW
Colloids Surf B Biointerfaces; 2012 Sep; 97():207-10. PubMed ID: 22609605
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.
Bubber P; Haroutunian V; Fisch G; Blass JP; Gibson GE
Ann Neurol; 2005 May; 57(5):695-703. PubMed ID: 15852400
[TBL] [Abstract][Full Text] [Related]
40. Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits.
Krishnan B; Kayed R; Taglialatela G
Alzheimers Dement (N Y); 2018; 4():89-102. PubMed ID: 29560412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
